| Naloxazone | |
|---|---|
|
(5α)- 17-allyl- 3,14-dihydroxy- 4,5-epoxymorphinan- 6-one hydrazone |
|
|
Other names
Naloxone- 6-hydrazone |
|
| Identifiers | |
| CAS number | 73674-85-8 |
| PubChem | 9576788 |
| ChEMBL | CHEMBL354010 |
| Jmol-3D images | {{#if:C=CCN1CCC23C4C(=NN)CCC2
(C1CC5=C3C(=C(C=C5)O)O4)O|Image 1 |
|
|
| Properties | |
| Molecular formula | C19H23N3O3 |
| Molar mass | 341.4 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Naloxazone is an irreversible μ opioid receptor antagonist which is selective for the μ1 receptor subtype.[1] Naloxazone produces very long lasting antagonist effects as it forms a covalent bond to the active site of the mu-opioid receptor,[2] thus making it impossible for the molecule to unbind and blocking the receptor permanently until the receptor is recycled by endocytosis.
It has been reported that naloxazone is unstable in acidic solution, dimerizing into the more stable and much more potent antagonist naloxonazine.[3] Under conditions in which no naloxonazine formation could be detected, naloxazone did not display irreversible μ opioid receptor binding.[3]
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)